Hiv Infection Clinical Trials 2023

What Are HIV infection Clinical Trials?

The virus known as HIV targets the immune system of the human body. If left untreated, HIV can lead to AIDS. Scientists have not yet found an effective cure for HIV. Individuals who contract HIV are permanently infected.

However, people living with HIV can manage the disease with the proper medical treatment. HIV infection clinical trials can help in the management of symptoms, the search for potential treatments, and the development of HIV preventive strategies.

Why Is HIV Infection Being Studied Through Clinical Trials?

By the conclusion of 2021, approximately 38.4 million individuals worldwide were declared HIV positive. According to estimates, 0.7% of individuals in the globe between the ages of 15 to 49 have HIV. At the same time, the severity of the disease continues to differ greatly between different areas worldwide.

HIV infection clinical trials can aid in the discovery of potential prevention strategies to lower the rising number of HIV-positive and HIV-infected individuals. It can also help in the discovery of potential therapies to aid in the better management of symptoms.

What Are The Types Of Treatments Available For HIV Infection?

Individuals with HIV must live with the illness for the rest of their lives because there is no known cure. However, several drugs help manage HIV and avoid side effects. Antiretroviral treatment is the name given to these drugs. Regardless of the stage, doctors immediately start people diagnosed with HIV on Antiretroviral therapy.

ART often consists of a combination of drugs from several pharmacological classes together. This is the most effective treatment for reducing HIV in the bloodstream. Many ART regimens consist of a single daily tablet containing several HIV medicines. Here are two common Antiretroviral treatments for HIV:

Cabotegravir

Antiretroviral medicine cabotegravir, marketed underneath the trade name Vocabria is used by doctors to treat HIV. It comes in the form of intramuscular injections and tablets.

Temixys

Temixys is used to treat HIV-1 infection in children and adults who weigh at least 35 kg. The medication is often prescribed along with other antiretroviral medications.

What Are Some Recent Breakthrough Clinical Trials for HIV infection?

In recent years, there have been several notable HIV infection clinical trials. Some of the breakthrough HIV infection clinical trials are:

2017: Trial of Long-Acting Injectable Medicine for HIV Prevention- This study investigates a long-acting injectable drug for preventing HIV in sexually active females. The experimental anti-HIV medicine cabotegravir, administered intravenously once every eight weeks, is being studied in eastern and southern African regions to see if it may effectively safeguard women susceptible to contracting HIV.

2023: Progress toward HIV cure- This study demonstrates how experimental drugs have the potential to enhance the body's natural capacity to inhibit HIV. According to experts, it is a significant leap toward a cure.

Who Are Some of The Key Opinion Leaders / Researchers in HIV infection Clinical Trial Research?

University Of California San Francisco

UCSF collects high amounts of NIH research funding and funds for HIV/AIDS investigation. The organization contributes to several current studies aimed at HIV prevention and potential cure research.

John Hopkins Medicine

John Hopkins Medicine has employed several HIV researchers carrying out ongoing clinical trials and research aiming to advance HIV/AIDS treatment, management, and diagnosis of HIV.